GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Egyptian International Pharmaceutical Investments (CAI:PHAR) » Definitions » Cyclically Adjusted PB Ratio

Egyptian International Pharmaceutical Investments (CAI:PHAR) Cyclically Adjusted PB Ratio : 1.63 (As of Jun. 09, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Egyptian International Pharmaceutical Investments Cyclically Adjusted PB Ratio?

As of today (2024-06-09), Egyptian International Pharmaceutical Investments's current share price is E£36.40. Egyptian International Pharmaceutical Investments's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was E£22.31. Egyptian International Pharmaceutical Investments's Cyclically Adjusted PB Ratio for today is 1.63.

The historical rank and industry rank for Egyptian International Pharmaceutical Investments's Cyclically Adjusted PB Ratio or its related term are showing as below:

CAI:PHAR' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.06   Med: 1.47   Max: 2.17
Current: 1.63

During the past years, Egyptian International Pharmaceutical Investments's highest Cyclically Adjusted PB Ratio was 2.17. The lowest was 1.06. And the median was 1.47.

CAI:PHAR's Cyclically Adjusted PB Ratio is ranked better than
54.99% of 742 companies
in the Drug Manufacturers industry
Industry Median: 1.875 vs CAI:PHAR: 1.63

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Egyptian International Pharmaceutical Investments's adjusted book value per share data for the three months ended in Dec. 2023 was E£28.620. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is E£22.31 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Egyptian International Pharmaceutical Investments Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Egyptian International Pharmaceutical Investments's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egyptian International Pharmaceutical Investments Cyclically Adjusted PB Ratio Chart

Egyptian International Pharmaceutical Investments Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1.72 1.35 1.64

Egyptian International Pharmaceutical Investments Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.35 1.21 1.24 1.56 1.64

Competitive Comparison of Egyptian International Pharmaceutical Investments's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Egyptian International Pharmaceutical Investments's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Egyptian International Pharmaceutical Investments's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Egyptian International Pharmaceutical Investments's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Egyptian International Pharmaceutical Investments's Cyclically Adjusted PB Ratio falls into.



Egyptian International Pharmaceutical Investments Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Egyptian International Pharmaceutical Investments's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=36.40/22.31
=1.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Egyptian International Pharmaceutical Investments's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Egyptian International Pharmaceutical Investments's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=28.62/129.4194*129.4194
=28.620

Current CPI (Dec. 2023) = 129.4194.

Egyptian International Pharmaceutical Investments Quarterly Data

Book Value per Share CPI Adj_Book
201403 13.121 99.695 17.033
201406 13.760 100.560 17.709
201409 14.319 100.428 18.453
201412 12.429 99.070 16.237
201503 13.308 99.621 17.289
201506 13.999 100.684 17.994
201509 15.040 100.392 19.389
201512 12.874 99.792 16.696
201603 13.779 100.470 17.749
201606 14.598 101.688 18.579
201609 3.577 101.861 4.545
201612 16.512 101.863 20.979
201703 15.175 102.862 19.093
201706 0.000 103.349 0.000
201709 18.643 104.136 23.169
201712 19.569 104.011 24.349
201803 17.121 105.290 21.045
201806 19.106 106.317 23.258
201809 19.326 106.507 23.484
201812 21.539 105.998 26.298
201903 19.369 107.251 23.373
201906 20.764 108.070 24.866
201909 21.723 108.329 25.952
201912 22.879 108.420 27.310
202003 20.135 108.902 23.929
202006 20.647 108.767 24.567
202009 21.254 109.815 25.048
202012 22.419 109.897 26.402
202103 20.995 111.754 24.314
202106 21.711 114.631 24.512
202109 22.394 115.734 25.042
202112 23.040 117.630 25.349
202203 21.717 121.301 23.170
202206 22.283 125.017 23.068
202209 23.375 125.227 24.158
202212 25.124 125.222 25.966
202303 26.308 127.348 26.736
202306 26.755 128.729 26.899
202309 27.415 129.860 27.322
202312 28.620 129.419 28.620

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Egyptian International Pharmaceutical Investments  (CAI:PHAR) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Egyptian International Pharmaceutical Investments Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Egyptian International Pharmaceutical Investments's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Egyptian International Pharmaceutical Investments (CAI:PHAR) Business Description

Traded in Other Exchanges
N/A
Address
1st Industrial Zone B1, EIPICO, 10th of Ramadan, EGY
Egyptian International Pharmaceutical Investments is an Egypt based company pharmaceutical generic drugs. It holds license agreements with a group of pharmaceutical companies to produce their products locally and replace the imported ones. The company produces dosage forms, Spansule capsules, non-traditional dosage forms including soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets. It exports its products to Arab countries, African, Asian and East European Countries. Its products portfolio includes antibiotics, anesthetics, analgesics, antihypertensives, cholesterol-lowering medications, ophthalmic products, blood substitutes and restoratives, dermatological drugs and vitamins. Some of its products are Vasotec, Co-vasotec, Flumox, and Cefotax.